Drugs Made In America Acquisition II LLC 4
4 · Drugs Made In America Acquisition II Corp. · Filed Oct 1, 2025
Insider Transaction Report
Form 4
Transactions
- Other
Ordinary shares
2025-09-26−400,000→ 14,675,000 total - Sale
Ordinary shares
2025-09-26−7,966,667→ 6,708,333 total - Purchase
Ordinary shares
2025-09-26+700,000→ 15,075,000 total - Purchase
Rights to receive ordinary shares
2025-09-26+700,000→ 700,000 total→ Ordinary shares (700,000 underlying)
Footnotes (4)
- [F1]Reflects 700,000 private units acquired by the reporting person, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $7,000,000.
- [F2]As of the Transaction Date, the reporting person transferred an aggregate of 400,000 ordinary shares to certain of the Issuer's officers and directors for no consideration.
- [F3]As of the Transaction Date, pursuant to share transfer agreements, the reporting person transferred an aggregate of 7,966,667 ordinary shares to a number of accredited investors for consideration ranging from no consideration to $1.50 per share.
- [F4]The rights convert automatically into ordinary shares at the completion of the Issuer's initial business combination.